Devices Pique Private Equity's Interest

The spate of recent carve-outs from Boston Scientific has private equity and venture capital investors hungry for similar deals across the industry. But device companies don't seem to be serving much up.

By Tom Salemi

Boston Scientific Corp. has spent the last year carving itself up like a Thanksgiving turkey. The company—still working through...

More from Business Strategy

More from In Vivo